DSM-Firmenich AG/€DSFIR
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About DSM-Firmenich AG
DSM-Firmenich AG, established in May 2023 through the merger of Dutch company DSM N.V. and Swiss company Firmenich SA, operates in the nutrition, health, and beauty industries. The company is organized into four segments: Perfumery & Beauty, offering fragrance solutions; Taste, Texture & Health, providing food and beverage ingredients; Health, Nutrition & Care, delivering dietary supplements and medical nutrition products; and Animal Nutrition & Health, supplying animal feed ingredients. Headquartered in Kaiseraugst, Switzerland, and Maastricht, Netherlands, DSM-Firmenich has operations in nearly 60 countries and employs approximately 30,000 people. The merger combines DSM's expertise in health and nutrition with Firmenich's capabilities in perfumery and taste, positioning the company to offer integrated solutions across its sectors. (,)
Ticker
€DSFIR
Sector
Primary listing
AEX
Industry
Chemicals
Headquarters
Kaiseraugst, Switzerland
Employees
26,301
ISIN
CH1216478797
Website
DSM-Firmenich AG Metrics
BasicAdvanced
€24B
96.53
€0.94
-
€2.50
1.17%
Price and volume
Market cap
€24B
52-week high
€121.54
52-week low
€80.37
Average daily volume
414K
Dividend rate
€2.50
Financial strength
Current ratio
2.018
Quick ratio
1.25
Long term debt to equity
19.58
Total debt to equity
23.263
Dividend payout ratio (TTM)
266.80%
Interest coverage (TTM)
4.19%
Profitability
EBITDA (TTM)
1,599
Gross margin (TTM)
33.17%
Net profit margin (TTM)
1.95%
Operating margin (TTM)
4.38%
Effective tax rate (TTM)
34.43%
Revenue per employee (TTM)
€490,000
Management effectiveness
Return on assets (TTM)
1.03%
Return on equity (TTM)
1.22%
Valuation
Price to earnings (TTM)
96.526
Price to revenue (TTM)
1.885
Price to book
1.07
Price to tangible book (TTM)
5.43
Price to free cash flow (TTM)
23.798
Free cash flow yield (TTM)
4.20%
Free cash flow per share (TTM)
383.22%
Dividend yield (TTM)
2.74%
Forward dividend yield
1.17%
Growth
Revenue change (TTM)
20.44%
Earnings per share change (TTM)
-89.71%
3-year revenue growth (CAGR)
20.75%
10-year revenue growth (CAGR)
6.14%
3-year earnings per share growth (CAGR)
-53.88%
10-year earnings per share growth (CAGR)
1.95%
10-year dividend per share growth (CAGR)
4.24%
Bulls say / Bears say
DSM-Firmenich's strategic divestment of its stake in the Feed Enzyme alliance for approximately €1.5 billion strengthens its balance sheet and aligns with its focus on core businesses, potentially enhancing shareholder value. (Investing.com)
The company's announcement of a share buyback program up to €1 billion demonstrates confidence in its financial health and commitment to returning value to shareholders. (TradingView News)
DSM-Firmenich's adjusted EBITDA margin improved to 19.9% in Q1 2025, indicating enhanced operational efficiency and profitability. (TradingView News)
A U.S. federal judge ruled that DSM-Firmenich must face lawsuits alleging price-fixing in the fragrance industry, which could lead to financial penalties and reputational damage. (Reuters)
The company reported Q1 2025 adjusted core profit slightly below market expectations, which may raise concerns about its short-term financial performance. (TradingView News)
DSM-Firmenich is working to mitigate the impact of U.S. tariffs on its business, but these trade barriers could still affect profitability and market competitiveness. (TradingView News)
Data summarised monthly by Lightyear AI. Last updated on 3 Jul 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for DSM-Firmenich AG stock?
DSM-Firmenich AG (DSFIR) has a market cap of €24B as of July 12, 2025.
What is the P/E ratio for DSM-Firmenich AG stock?
The price to earnings (P/E) ratio for DSM-Firmenich AG (DSFIR) stock is 96.53 as of July 12, 2025.
Does DSM-Firmenich AG stock pay dividends?
Yes, the DSM-Firmenich AG (DSFIR) stock pays dividends to shareholders. As of July 12, 2025, the dividend rate is €2.5 and the yield is 1.17%. DSM-Firmenich AG has a payout ratio of 266.8% on a trailing twelve-month basis.
When is the next DSM-Firmenich AG dividend payment date?
The next DSM-Firmenich AG (DSFIR) dividend payment date is unconfirmed.
What is the beta indicator for DSM-Firmenich AG?
DSM-Firmenich AG (DSFIR) does not currently have a Beta indicator.